CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression

Cell Death and Differentiation

Volumn 18, Issue 7, 2011, Pages 1174-1183

  Liu, Z ^a   Yang, X ^a   Li, Z ^a   McMahon, C ^a   Sizer, C ^a   Barenboim Stapleton, L ^a   Bliskovsky, V ^a   Mock, B ^a   Ried, T ^a   London, W B ^b   Maris, J ^c   Khan, J ^a   Thiele, C J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CASZ1; chromosome 1p; developmental gene; neuroblastoma; transcription factor; tumor suppressor

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CASZ 1 GENE; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CHROMOSOME MAP; CONTROLLED STUDY; DROSOPHILA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; NEUROBLASTOMA; NUCLEAR PROTEINS; NUCLEAR REPROGRAMMING; ONCOGENE PROTEINS; RETINOIDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 79958804414     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.187     Document Type: Article

References (40)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-216. (Pubitemid 37328872)
2. Bagchi A, Mills AA. The quest for the 1p36 tumor suppressor. Cancer Res 2008; 68: 2551-2556. (Pubitemid 351556249)
3. Caren H, Fransson S, Ejeskar K, Kogner P, Martinsson T. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer 2007; 97: 1416-1424. (Pubitemid 350114785)
4. Liu Z, Yang X, Tan F, Cullion K, Thiele CJ. Molecular cloning and characterization of human castor, a novel human gene upregulated during cell differentiation. Biochem Biophys Res Commun 2006; 344: 834-844.
5. Mellerick DM, Kassis JA, Zhang SD, Odenwald WF. Castor encodes a novel zinc finger protein required for the development of a subset of CNS neurons in Drosophila. Neuron 1992; 9: 789-803.
6. Isshiki T, Pearson B, Holbrook S, Doe CQ. Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny. Cell 2001; 106: 511-521. (Pubitemid 32786994)
7. Cui X, Doe CQ. Ming is expressed in neuroblast sublineages and regulates gene expression in the Drosophila central nervous system. Development 1992; 116: 943-952. (Pubitemid 23042435)
8. von Hilchen CM, Beckervordersandforth RM, Rickert C, Technau GM, Altenhein B. Identity, origin, and migration of peripheral glial cells in the Drosophila embryo. Mech Dev 2008; 125: 337-352.
9. Christine KS, Conlon FL. Vertebrate castor is required for differentiation of cardiac precursor cells at the ventral midline. Dev Cell 2008; 14: 616-623. (Pubitemid 351479934)
10. Vacalla CM, Theil T. Cst, a novel mouse gene related to Drosophila castor, exhibits dynamic expression patterns during neurogenesis and heart development. Mech Dev 2002; 118: 265-268. (Pubitemid 35292150)
11. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 1991; 2: 245-255.
12. Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004; 5: 539-551. (Pubitemid 38748916)
13. Weissman AM. How much REST is enough? Cancer Cell 2008; 13: 381-383. (Pubitemid 351609450)
14. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009; 27: 289-297.
15. Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G et al. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J Natl Cancer Inst 2009; 101: 663-677.
16. Schulte JH, Pentek F, Hartmann W, Schramm A, Friedrichs N, Ora I et al. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Int J Cancer 2009; 124: 2488-2494.
17. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-854. (Pubitemid 23084339)
18. Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V et al. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst 2008; 100: 940-949. (Pubitemid 351957513)
19. Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D et al. CHD5 is a tumor suppressor at human 1p36. Cell 2007; 128: 459-475. (Pubitemid 46198889)
20. Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Develop 2008; 22: 884-893. (Pubitemid 351482842)
21. Munirajan AK, Ando K, Mukai A, Takahashi M, Suenaga Y, Ohira M et al. KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 2008; 283: 24426-24434.
22. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P et al. The MYCN oncogene is a direct target of miR-34a. Oncogene 2008; 27: 5204-5213.
23. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM et al. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735-742.
24. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M et al. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 2005; 24: 2684-2694. (Pubitemid 40593096)
25. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 1995; 55: 505-509.
26. Brody T, Odenwald WF. Cellular diversity in the developing nervous system: a temporal view from Drosophila. Development 2002; 129: 3763-3770. (Pubitemid 34994008)
27. Fodde R, Smits R. Cancer biology. A matter of dosage. Science 2002; 298: 761-763.
28. Krygier S, Djakiew D. Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer 2002; 98: 1-7. (Pubitemid 34113409)
29. Jin H, Pan Y, He L, Zhai H, Li X, Zhao L et al. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res 2007; 5: 423-433. (Pubitemid 46903951)
30. Takeda T, Hattori N, Tokuhara T, Nishimura Y, Yokoyama M, Miyake M. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 2007; 67: 1744-1749. (Pubitemid 46383401)
31. Yoon KJ, Phelps DA, Bush RA, Remack JS, Billups CA, Khoury JD. ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma. PLoS One 2008; 3: e3629.
32. Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res 2004; 64: 6109-6118. (Pubitemid 39129411)
33. Timeus F, Crescenzio N, Valle P, Pistamiglio P, Piglione M, Garelli E et al. Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Exp Hematol 1997; 25: 1253-1260. (Pubitemid 27508873)
34. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6. (Pubitemid 38391943)
35. Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985; 313: 404-406. (Pubitemid 15198727)
36. Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F et al. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res 2002; 62: 5158-5167. (Pubitemid 35024586)
37. Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R et al. TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J Biol Chem 2006; 281: 11260-11270. (Pubitemid 43855551)
38. Ramos A, Ho WC, Forte S, Dickson K, Boutilier J, Favell K et al. Hypo-osmolar stress induces p75NTR expression by activating Sp1-dependent transcription. J Neurosci 2007; 27: 1498-1506.
39. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J Royal Stat Soc A 1972; 135: 185-198.
40. Cox D. Regression models and life tables (with discussion). J Royal Stat Soc B 1972; 34: 187-220.